InvestorsHub Logo
Followers 10
Posts 778
Boards Moderated 0
Alias Born 03/18/2003

Re: Millstone post# 33365

Monday, 11/09/2015 7:10:07 PM

Monday, November 09, 2015 7:10:07 PM

Post# of 459598

This quote from Dr. Missling in this morning's press release really stood out to me along with a number of other great quotes:

“While we remain focused on Alzheimer’s, the remarkably fast onset of clinical effect of ANAVEX 2-73 increases our options to potentially pursue additional indications for diseases characterized by working memory impairment and may enable clinical trials to be completed within shorter time frames.” [emphasis added]

Could this be hinting at a fast track designation for Parkinsons, Epilepsy, Alzheimers, or?


Could be. But I recall Dr. Missling mentioning that he was hoping to go into a P3 with as few as 100-300 patients. Does anyone recall this? I may very well be wrong.

IMHO
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News